Saturday, September 6, 2008
Spectranetics Announces Federal Investigation, USA
Spectranetics Corporation (Nasdaq:SPNC) was jointly served by the Food and Drug Administration (FDA) and U.S. Immigration and Customs Enforcement (ICE) this morning with a search warrant issued by the United States District Court, District of Colorado.
Subscribe to:
Post Comments (Atom)
2 comments:
That's because doctors tend to continue patients on the more expensive brand name drug in the sample, rather than switch them over to a cheaper generic later on, researchers say
The current finding follows on the heels of a University of Chicago Medical Center study released this past spring that indicated that patients who receive free drug samples go on to incur significantly higher out-of-pocket expenses when filling their prescriptions than those who never get such freebies. In that instance, three-quarters of the patients had private insurance coverage.
Post a Comment